| 000 | 01125 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518031421.0 | ||
| 264 | 0 | _c20200511 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1878-5832 | ||
| 024 | 7 |
_a10.1016/j.drudis.2019.03.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMietzner, Raphael | |
| 245 | 0 | 0 |
_aCausative glaucoma treatment: promising targets and delivery systems. _h[electronic resource] |
| 260 |
_bDrug discovery today _c08 2019 |
||
| 300 |
_a1606-1613 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aGlaucoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta2 _xmetabolism |
| 650 | 0 | 4 |
_arho-Associated Kinases _xmetabolism |
| 700 | 1 | _aBreunig, Miriam | |
| 773 | 0 |
_tDrug discovery today _gvol. 24 _gno. 8 _gp. 1606-1613 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.drudis.2019.03.017 _zAvailable from publisher's website |
| 999 |
_c29510995 _d29510995 |
||